NCT01319201

Brief Summary

Part I: Survey of Coronary Artery Calcification and Stenosis in Participants with Different Glycaemic Status Aims: To evaluate coronary artery calcification and stenosis in community-dwelling adults with different glycaemic status, using dual-source CT angiography (CTA) Study Subjects and Methods: 200 adults with normal glucose regulation (NGR), 200 with impaired glucose regulation (IGR) and 200 with type 2 diabetes were recruited from an urban community of Shanghai, who then underwent a comprehensive examination including questionnaire, anthropometric measurements, biochemical analysis and CTA. Part II: Follow-up of Cardiovascular Events and Re-evaluation of Coronary Artery Calcification and Stenosis Aims and Methods: To investigate the development of cardiovascular diseases in subjects recruited in part I and re-evaluate coronary artery calcification and stenosis using CTA after 3-year follow-up To identify the predictive value of coronary artery calcification and stenosis with future risks of cardiovascular diseases and the possible development of coronary artery disorders among participants with different glycaemic status

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2010

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

March 18, 2011

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 21, 2011

Completed
Last Updated

March 21, 2011

Status Verified

March 1, 2011

First QC Date

March 18, 2011

Last Update Submit

March 18, 2011

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of participants who will develop cardiovascular events during follow-up

    Cardiovascular events include non-fatal myocardial infarction, non-fatal stroke and cardiovascular death. The progression of coronary artery calcium and stenosis is also evaluated at the final visit.

    3 years

Study Arms (3)

Impaired glucose regulation

This group of subjects was diagnosed as impaired glucose regulation using oral glucose tolerance test.

Type 2 diabetes

This group of subjects was diagnosed as type 2 diabetes using oral glucose tolerance test.

Normal glucose regulation

This group of subjects was considered normal regarding glucose metabolism using oral glucose tolerance test.

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

200 adults with normal glucose regulation (NGR), 200 with impaired glucose regulation (IGR) and 200 with type 2 diabetes were recruited from an urban community of Shanghai

You may qualify if:

  • Age between 40 and 70 years old
  • Gender: males and females
  • Provide written informed consent
  • Satisfactory compliance

You may not qualify if:

  • History of cardiovascular diseases
  • Allergy to iodine
  • Exposure to radiation within last 3 months
  • ALT more than 100IU/L, or serum creatine more than 133μmol/l \[1.5mg/dl\] or GFR less than 60ml/min
  • Heart rate more than 100 bpm or severe arrhythmia
  • Malignancy, myocardial infection, acute hepatitis or other major diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Jiao-Tong University School of Medicine

Shanghai, 200025, China

Location

Biospecimen

Retention: SAMPLES WITH DNA

Blood and urine samples were collected and retained for biomarker analysis

MeSH Terms

Conditions

Thromboembolism

Condition Hierarchy (Ancestors)

Embolism and ThrombosisVascular DiseasesCardiovascular Diseases

Study Officials

  • Guang Ning, M.D.; PH.D.

    Shanghai Jiao Tong University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 18, 2011

First Posted

March 21, 2011

Study Start

April 1, 2010

Last Updated

March 21, 2011

Record last verified: 2011-03

Locations